Research › Fact Sheets › KVUE

KENVUE INC.

LISTEDNYSE

SYMBOLKVUE

SIC2844

STATE OF INC.DE

FISCAL YEAR ENDSJanuary 3

CIK1944048

PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · LARGE ACCELERATED FILER · 5 FISCAL YEARS OF SEC XBRL DATA, 2022–2025

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/28/25

($ millions)	Amount	%
Total debt	9,224	46.1
Stockholders' equity	10,765	53.9
Total capitalization	19,989	100.0

1,920,773,467 shares outstanding at 31 July 2026 (cover page of the 10-Q filed 6 August 2026).

LONG-TERM DEBT 12/28/25

($ millions)	Amount
Long-term debt, incl. current maturities	8,524
Current maturities	750
Short-term borrowings / commercial paper	700

CAPITAL STOCK 12/28/25

Common shares authorized	12,500,000,000
Common shares issued	1,936,502,167
Treasury shares	20,387,000
Par or stated value per share ($)	0.01
Preferred stock ($ millions)	0
Outstanding at 7/31/26	1,920,773,467

DIVIDENDS DECLARED/PAID

Fiscal year	Per share $	Payout %
2025	0.82	108.6
2024	0.81	150.0
2023	0.40	44.4
2023	–	–
2022	–	–

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware. Formerly known as JNTL, Inc. (to 30 August 2022).

BUSINESS: Classified by the SEC under Standard Industrial Classification 2844, Perfumes, Cosmetics & Other Toilet Preparations. Large accelerated filer. Principal executive office: 1 Kenvue Way, Summit, NJ 07901. Fiscal year ends January 3. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)	12/28/25	12/29/24	12/31/23
Revenues	15,124	15,455	15,444
Cost of revenues	6,332	6,496	6,801
Gross profit	8,792	8,959	8,643
Research and development	382	408	399
Selling, general and administrative	6,088	6,329	6,141
Depreciation and amortization	557	622	627
Operating income	2,414	1,841	2,512
Interest expense	430	431	250
Income before income taxes	1,999	1,415	2,190
Income taxes	529	385	526
Net income	1,470	1,030	1,664
Earned per share, diluted ($)	0.76	0.54	0.90
Dividends per share ($)	0.82	0.81	0.40

CONSOLIDATED BALANCE SHEET

($ millions)	12/28/25	12/29/24
Cash and equivalents	1,062	1,070
Receivables, net	2,382	2,165
Inventories	1,666	1,591
Total current assets	5,697	5,525
Property, plant and equipment, net	2,212	1,849
Goodwill	9,509	8,843
Total assets	27,076	25,601
Total current liabilities	5,945	5,739
Total liabilities	16,311	15,933
Stockholders' equity	10,765	9,668
Total liabilities and equity	27,076	25,601

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year ended	Revenues	Oper. income	Net income	Net margin %	EPS diluted $	Div. per share $	Oper. cash flow	Capital expend.	Free cash flow	Total assets	Total liabilities	Total debt	Stockholders' equity	ROE %	Debt / equity
12/28/25	15,124	2,414	1,470	9.7	0.76	0.82	2,197	475	1,722	27,076	16,311	9,224	10,765	13.7	0.86
12/29/24	15,455	1,841	1,030	6.7	0.54	0.81	1,769	434	1,335	25,601	15,933	9,407	9,668	10.7	0.97
12/31/23	15,444	2,512	1,664	10.8	0.90	0.40	3,168	469	2,699	27,851	16,640	8,287	11,211	14.8	0.74
1/1/23	14,950	2,675	2,064	13.8	1.20	–	2,525	375	2,150	27,316	7,346	0	19,970	10.3	0.00
1/2/22	15,054	2,920	2,078	13.8	1.21	–	334	295	39	–	–	–	20,491	10.1	–

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

Kenvue Inc.
CIK 1944048 · EIN 88-1032011

PRINCIPAL OFFICE:

1 Kenvue Way, Summit, NJ 07901
Tel.: 908-874-1200

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

2844 · Perfumes, Cosmetics & Other Toilet Preparations

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/28/25, filed 20 February 2026

FORMER NAMES:

JNTL, Inc.

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/13/26	8-K	period 10/9/26
8/6/26	10-Q	period 6/28/26
8/6/26	8-K	period 8/6/26
5/22/26	8-K	period 5/21/26
5/7/26	10-Q	period 3/29/26
5/7/26	8-K	period 5/7/26
4/15/26	8-K	period 4/10/26
4/8/26	DEF 14A	period 12/28/25

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/20/26) · 10-K FY2024 (filed 2/24/25) · 10-K FY2023 (filed 3/1/24). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.